Definium Therapeutics (DFTX) Profit After Tax (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.86% |
| Dec 31, 2025 | 25.02% |
| Sep 30, 2025 | -57.37% |
| Jun 30, 2025 | -83.07% |
| Mar 31, 2025 | 32.79% |
| Dec 31, 2024 | -153.88% |
| Sep 30, 2024 | -133.75% |
| Jun 30, 2024 | 89.24% |
| Mar 31, 2024 | -127.96% |
| Dec 31, 2023 | -33.15% |
| Sep 30, 2023 | 38.47% |
| Jun 30, 2023 | -17.39% |
| Mar 31, 2023 | -406.12% |
| Dec 31, 2022 | 70.26% |
| Sep 30, 2022 | 2.78% |
| Jun 30, 2022 | 8.10% |
| Mar 31, 2022 | -9.64% |
| Dec 31, 2021 | 2.13% |
| Sep 30, 2021 | 62.00% |
| Jun 30, 2021 | -228.89% |
| Mar 31, 2021 | 1.19% |
| Dec 31, 2020 | -60.52% |
| Sep 30, 2020 | -51.74% |
| Jun 30, 2020 | 18.57% |
| Mar 31, 2020 | -86.43% |